Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    2530
    PDF: 946
    HTML: 306
  • EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

    Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.032
    893
    PDF: 620
    HTML: 87
  • THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

    Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri
    e2022012
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.012
    1809
    PDF: 3239
    HTML: 414
  • TYPICAL AND ATYPICAL PRESENTATION OF COVID-19 INFECTION IN CHILDREN IN THE TOP OF PANDEMIC IN MINIA GOVERNORATE (TWO CENTER EXPERIENCE)

    Madeha Abdalla Sayed, Mohamed Abdelhakeem
    e2022002
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.002
    1614
    PDF: 595
    HTML: 267
  • The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.

    Sumeyye Kazancioglu, Ebru Ayöztürk, Seval Izdes, Rahmet Guner
    e2026050
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.050
    74
    PDF: 77
    HTML: 3
  • COVID-19 induces prolonged immunological exhaustion leading to relapse of hematological malignancies except in hematopoietic cell transplant recipients

    SUPARNO CHAKRABARTI, Snigdha Banerjee, Mahak Agarwal, Gitali Bhagawati, Nilanjan Saha, SARITA JAISWAL
    e2025042
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.042
    1042
    PDF: 748
    HTML: 126
  • GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

    Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis
    e2025014
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.014
    1397
    HTML: 157
    PDF: 879
  • CLINICAL SIGNS AND TREATMENT OF NEW-ONSET BONE MARROW FAILURE ASSOCIATED SARS-COV-2 INFECTION IN CHILDREN : A SINGLE INSTITUTION PROSPECTIVE COHORT STUD

    Mervat A M youssef, Ebtisam Shawky hmed, Dalia Tarik Kamal, khalid Elsayh,, Mai A Abdelfatta, Hyam Hassan Mahran Mahran, Mostafa M Embaby
    e2024034
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.034
    1221
    PDF: 1307
    HTML: 123
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2621
    PDF: 944
    HTML: 551
  • A MULTICENTRE ICET-A STUDY OF CONFIRMED SARS-COV-2 INFECTION IN PATIENTS WITH HEMOGLOBINOPATHIES: PRELIMINARY DATA FROM 10 COUNTRIES

    Vincenzo De Sanctis
    e2020046
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.046
    2903
    PDF: 1585
    HTML: 314
  • PRE AND POST-MONOCLONAL INFUSION NEUTRALIZING ACTIVITY IN A SUBGROUP OF PATIENTS TREATED IN THE PRESENCE OF TWO SARS-COV-2 DOMINANT VARIANT OF CONCERN (VOCS) AND AN ONGOING VACCINATION. OVERALL CLINICAL EFFICACY OF TWO MONOCLONAL ANTIBODIES ASSOCIATION IN UMBRIA

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Anna Gidari, Lisa Malincarne, Sara Benedetti , Alessandra Lanzi, Sabrina Bastianelli, Sara Pierucci, Chiara busti, Daniela Francisci
    e2022050
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.050
    1666
    PDF: 546
    HTML: 232
  • IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

    İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
    e2022074
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.074
    1564
    PDF: 798
    HTML: 211
  • Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

    Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team
    e2024043
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.043
    1310
    PDF: 946
    HTML: 91
  • Mild clinical course of COVID-19 infection in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs) without interruption

    Judit Demeter, Julia Weisinger, Zsolt Nagy
    e2021022
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.022
    1428
    PDF: 492
    HTML: 232
  • A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid

    Irina Panovska-Stavridis
    e2021048
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.048
    1323
    PDF: 477
    HTML: 402
  • Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections

    Macoura Gadji, Youssou Bamar Gueye, David Motto, Saliou Diop
    e2024008
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.008
    1609
    PDF: 1301
    HTML: 150
  • The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients

    Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim
    e2020082
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.082
    1003
    PDF: 367
    HTML: 207
  • CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

    Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano
    e2020042
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.042
    1464
    PDF: 952
    HTML: 405
  • THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

    Nicola Semeraro, Prof. Mario Colucci
    e2021045
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.045
    2002
    PDF: 821
    HTML: 225
  • THE DARK SIDE OF THE COVID-19 TREATMENTS ON MYCOBACTERIUM TUBERCULOSIS INFECTION

    Flavio De Maio, Delia Mercedes Bianco, Giovanni Delogu
    e2022021
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.021
    1295
    PDF: 760
    HTML: 233
  • COMPARISON OF THE CLINICAL AND LABORATORY FEATURES OF COVID AND INFLUENZA IN CHILDREN

    Davide Pata, Danilo Buonsenso, Piero Valentini
    e2022065
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.065
    1159
    PDF: 809
    HTML: 234
  • Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Coronavirus Disease 2019 (COVID-19) Pandemic: An Iranian Consensus

    Seied Asadollah Mousavi, Soroush Rad, Tahereh Rostami, Mohammad Vaezi, Hosein Kamranzadeh, Davood Babakhani, Sahar Tavakoli, Maryam Barkhordar, Tanaz Bahri, Amirabbas Hedayatiasl, azade kiumarsi
    e2020050
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.050
    1308
    PDF: 697
    HTML: 209
  • SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.

    Ilhami Berber, Ozlem Cagasar, Ahmet Sarıcı, Nurcan Kirici Berber, Ismet Aydogdu, Asli Yildirim, Harika Gozde Gocukara Bag, Leman Acun Delen, Ozkan Ulutas
    e2021009
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.009
    3350
    PDF: 1150
    HTML: 448
  • Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

    NICOLA SGHERZA, Stefania Zucano, Angelantonio Vitucci, Antonio Palma, Francesco Tarantini, Daniela Campanale, Luigi Vimercati, Angela Maria Vittoria Larocca, Domenico Visceglie, Amalia Acquafredda, Angelo Ostuni, Daniela Di Gennaro, Carmen Vitucci, Silvio Tafuri, Pellegrino Musto
    e2022056
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.056
    1164
    HTML: 293
    PDF: 507
  • EVALUATION OF ORAL DOXYCYCLINE, AZITHROMYCIN, OR SEQUENTIAL DOXYCYCLINE-AZITHROMYCIN TREATMENT FOR SCRUB TYPHUS-

    Hanchen Liu, Weizhen Wang, Yuqing Dong
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.020
    681
    PDF: 508
    HTML: 102
  • the EARLY TREATMENT WITH BAMLANIVIMAB ALONE DOES NOT PREVENT COVID-19 HOSPITALIZATION AND ITS POST-ACUTE SEQUELAE. A REAL EXPERIENCE IN UMBRIA, ITALY.

    Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Laura Martinelli Martinelli, lisa malincarne, Martina Savoia, Anna Laura Spinelli, Daniela Francisci
    e2021061
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.061
    1224
    PDF: 420
    HTML: 217
  • Neutropenıa Secondary to Sars-Cov2 Vaccınatıon in Post-Hematopoıetıc Stem Cell Transplant (Hsct) Patıents

    LUIS MIGUEL JUAREZ-SALCEDO, Samantha Feijóo, Cristina García, Alejandro Alonso, Beatriz Aguado, Javier Ortiz, Angela Figuera, Rafael de la Cámara
    e2023014
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.014
    990
    PDF: 934
    HTML: 368
  • Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts COVID-19 in cancer patients

    Alexandre Malek
    e2020044
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.044
    1214
    PDF: 796
    HTML: 222
  • EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies

    Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah , Azita Azarkeiva, Maryam Naderi , Sara Matin , Asghar Bazrafshan , Zohreh Zahedi , Afshan Shirkavand , Parisa pishdad, Vincenzo De Sanctis
    e2022026
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.026
    1702
    PDF: 734
    HTML: 234
  • Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

    Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti
    e2022043
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.043
    1367
    PDF: 590
    HTML: 224
  • NATION-WIDE SURVEY ON THE USE OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RA) FOR THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA IN CURRENT CLINICAL PRACTICE IN ITALY

    Francesco Rodeghiero, Dr. Mariasanta Napolitano, Nicola Vianelli, Lisanna Ghiotto, Silvia Cantoni, Giuseppe Carli, Monica Carpenedo, Valentina Carrai, Ugo Consoli, Gaetano Giuffrida, Elisa Lucchini, Elena Rossi, Cristina Santoro
    e2023019
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.019
    2036
    PDF: 1236
    PDF Appendix: 667
    HTML: 441
  • Management of pediatric rheumatological diseases during the outbreak of COVID-19: our experience

    Romina Gallizzi, Diana Sutera, Francesca Mazza, Alessandra Spagnolo, Giovanni Battista Pajno
    e2020049
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.049
    1085
    PDF: 752
    HTML: 199
  • The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

    Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso
    e2022041
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.041
    1276
    PDF: 772
    HTML: 320
  • EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA

    Linjuan Xu
    e2025058
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.058
    1492
    PDF: 790
    Suppl. Files: 329
    Html: 139
  • Immune thrombocytopenic purpura cases following COVID-19 vaccination.

    Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida
    e2021047
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.047
    1130
    PDF: 443
    HTML: 323
  • Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges

    Lorenza Torti, Francesco Sorrentino, Laura Maffei, Paolo De Fabritiis, Elisabetta Abruzzese
    e2023007
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.007
    1150
    PDF: 938
    HTML: 419
  • Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance

    Cristina Giubbilei, Elena Angeli, Fiammetta Fossi, Agnese Baffioni, Ginevra Giustini, Valentina Carrai
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.042
    166
    HTML: 85
    PDF: 121
  • The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases

    Laila Al Yazidi
    e2020074
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.074
    904
    PDF: 696
    HTML: 324
  • ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

    Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam
    e2022036
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.036
    884
    PDF: 527
    HTML: 394
  • Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

    Edoardo Olivari
    e2025040
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.040
    1061
    PDF: 781
    HTML: 156
  • Covid-19; Cholera and Crimean-Congo hemorrhagic fever in Iraq: A country with three outbreaks

    Nawfal R Hussein
    e2022077
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.077
    632
    PDF: 413
    HTML: 247
  • Delivery in asymptomatic Italian woman with SARS-CoV-2 infection. Delivery in asymptomatic woman with SARS-CoV-2 infection

    Giuseppe Vittorio De Socio, Lisa Malincarne, Saverio Arena, Stefania Troiani, Sara Benedetti, Barbara Camilloni, Giorgio Epicoco, Antonella Mencacci, Daniela Francisci
    e2020033
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.033
    1920
    PDF: 990
    HTML: 231
  • EFFICACY AND SAFETY OF THALIDOMIDE IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVALUATION

    Jialian Li, Ping Ji, Qinyue Zhong, Lin Dong, Hai Yi, Baiyu Chen, Xu Zhang, Tingting Duan
    e2026033
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.033
    243
    PDF: 248
    Suppl. Files: 41
    HTML: 16
  • Bacteraemia Among Patients with Sickle Cell Disease in Nigeria: Association with Spleen Size and Function

    adama isah ladu, Mairo Usman Kadaura, Mohammed Dauda, Abubakar Sadiq Baba, Caroline Jeffery, Abubakar Farate, Adekunle Adekile, Imelda Bates, Russell Dacombe
    e2023054
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.054
    803
    PDF: 521
    HTML: 131
  • SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

    Firas Kreidieh, Sally Temraz
    e2020078
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.078
    1090
    PDF: 968
    HTML: 340
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    756
    PDF: 589
    HTML: 33
  • DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS

    HADI YASSINE
    e2022076
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.076
    1375
    PDF: 1019
    HTML: 349
    Suppl. Figure: 184
    Suppl. Tables: 207
  • Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

    Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.030
    485
    PDF: 387
    HTML: 147
  • MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19

    XiaoTian Zhang, Yanhui Yu, Chao Zhang, Lijuan Zhao, Hongrui Wang, Guoqing Wang, Ming Yang
    e2022003
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.003
    1937
    PDF: 1106
    HTML: 312
  • PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS

    hend Attia
    e2023046
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.046
    1057
    PDF: 566
    HTML: 176
1 - 50 of 54 items 1 2 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.